ABSTRACT The aim of the present study was to evaluate the transfer of maternal dietary fatty acids (FA) from the yolk to the developing offspring, with special emphasis on n-3 FA eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Six hundred forty Ross 308 breeders were housed from 6 to 58 wk of age in 16 pens resulting in 4 replicates per dietary treatment. They were fed 1 of 4 diets: a basal diet, rich in n-6 FA (CON), or an n-3 FA enriched diet formulated to obtain an EPA/DHA ratio of 1/1 (EPA = DHA), 1/2 (DHA), or 2/1 (EPA). At 28, 43, and 58 wk of age, 20 eggs per treatment were collected and analyzed for FA composition. At these same breeder ages, 600 fertilized eggs per treatment were incubated. At hatch the residual yolks of 25 chicks per treatment were collected and analyzed for FA composition. At every hatch, 180 chicks per treatment were raised under standard conditions and livers were sampled at d 1, 14, 28, and 38 d for FA analysis. Concentrations of EPA in the yolk and residual yolk of eggs laid by EPA-fed breeders were highest, next-to-highest for EPA = DHA-fed breeders, next-tolowest for DHA-fed breeders, and lowest in those laid by control hens, reflecting the inclusion levels in the maternal diets. Yolk and residual yolk DHA concentrations, however, were not only elevated due to DHA supplementation, compared with the control diet, but also due to EPA supplementation. Offspring hepatic EPA concentrations were elevated until d 28 in all n-3 enriched groups, whereas hepatic DHA concentrations were only affected by EPA = DHA and DHA supplementation at d 1. No differences were found in hepatic DHA concentrations at later offspring ages. Considering the role of EPA and DHA in early development and growth, the maternal supply of these n-3 FA might improve offspring health and performance.
INTRODUCTION
Dietary fatty acids (FA) can be incorporated into the yolk of breeder eggs and therefore be available to the progeny early in their development (Koppenol et al., 2014a) . Of the 21-d development of the chick embryo, the last 7 d are an intense period of lipid metabolism and rapid embryonic growth (Freeman and Vince, 1974) . It has been estimated that more than 90% of the total energy requirement for embryonic development is derived from yolk lipid fatty acid oxidation (Freeman and Vince, 1974) . More than 80% of from n-3-rich eggs retained significantly higher levels of these FA up 42 d (Cherian, 2007) .
The current industry practice of feeding breeder hens diets high in n-6 FA limits the supply of essential n-3 PUFA to the hatchling. In particular, the n-3 long-chain PUFA, EPA and DHA, are essential for the optimal functioning of cells, brains, tissues, and organs because these FA form integral structural components of all cell membranes. Moreover, these long-chain n-3 FA play a crucial role in immunity (Calder, 2006) . The importance of simultaneously considering the relative amounts of DHA and EPA has been demonstrated in fish (McEvoy et al., 1998; Estevez et al., 1999; Sargent et al., 1999) . The simultaneous quantification of EPA and DHA is important because there are competitive interactions between them for the same enzymes for esterification into phospholipid structures (Mourente et al., 1991; Sargent et al., 1999) . Moreover, conversion of α-linolenic acid (ALA, 18:3n-3) to EPA and DHA occurs competitively with n-6 FA conversion of linoleic acid (LNA, to ARA. Therefore, accumulation of EPA and DHA in tissue is more effective when directly obtained from diet or when the competing amounts of n-6 are lower. This led us to the concept of supplementing broiler breeders diets, rich in n-6 FA, with n-3 FA, differing in EPA/DHA ratios. Recent work (Koppenol et al., 2014a) described that adding DHA and EPA at a ratio of 1/1, 1/2, and 2/1 resulted in similar ratios of these FA in the yolk. In the current study, the maternal transition of these FA built into the yolk is further investigated by measuring the FA concentration of the residual yolk (RY) and the liver of the offspring at different posthatch ages. Because it is known that the mechanisms involved in lipid metabolism and lipoprotein transfer are influenced by many factors such as breeder age (Nielsen, 1998; Burnham et al., 2001) , the potential effect of the breeder flock age on the FA transfer is taken into account, by setting up offspring from 28-, 43-, and 58-wk-old broiler breeders.
MATERIALS AND METHODS

Birds and Housing
In total, 640 Ross 308-broiler breeder hens (Belgabroed NV, Merksplas, Belgium) and their offspring were housed in the poultry experimental facility at the Institute for Agricultural and Fisheries Research (ILVO) as described by Koppenol et al. (2014a,b) . The breeder hens were randomly divided over the 4 dietary treatments differing in n-6/n-3 ratio and EPA/DHA ratio from 6 wk of age until 58 wk of age. The control diet was rich in n-6 FA, whereas the 3 other diets were enriched with n-3 FA. Each diet consisted of a 98.5% constant basal component (Table 1 ) and a varying 1.5% oil fraction. The 1.5% soybean oil in the control diet (CON) was replaced by fish oil blends to obtain 3 diets rich in n-3 FA. The objective of the formulation was to obtain EPA/DHA ratios of 1/1, 1/2, or 2/1 in the experimental diets: an n-3 rich diet in which EPA concentration almost equals DHA concentration (EPA = DHA diet), an n-3 rich diet in which the DHA concentration almost doubled the EPA concentration (DHA diet), or an n-3 rich diet in which the EPA concentration almost doubled the DHA concentration (EPA diet). Analysis of the feed showed EPA/DHA ratios were 0.8, 0.4, and 2.1 and n-6/n-3 ratios were 5.15, 5.79, and 5.38 for the EPA = DHA, DHA, and EPA diet, respectively. The n-6/n-3 ratio was 11.3 in the control diet as shown in Table 2 . Cockerels, receiving the control diet, were housed together with the breeders to obtain fertilized eggs, which were collected at 28, 43, and 58 wk of age. At these 3 time points (early, mid, and late in the production cycle), in total 600 eggs per treatment were collected for a maximum of 8 consecutive days, stored per pen, and incubated in a Petersime setter and hatcher at 37.6
• C and 45 to 50% RH during incubation and at 37.5
• C and 75 to 80% RH during hatch, respectively, as described in Koppenol et al. (2014b) . Eggs laid by breeders from the same pen were grouped on the same tray. For each pen, a tray of 150 eggs was filled, resulting in 2,400 eggs in total. After each incubation, a growth trial with 1,008 chicks was set up, as described in Koppenol et al. (2014b) . Offspring were sexed and placed in 24 pens of 42 chicks each, according to their maternal dietary treatment (252 chicks per treatment) and sex, resulting in 6 replicates per treatment (3 male and 3 female pens per treatment). The progeny was raised until slaughter age on a commercial diet, as described in Table 1 . The FA composition is given in Table 2 . Feed and water were provided ad libitum. This experiment was conducted in conformity with the public health service on humane care and use of laboratory animals policy and approved by the ILVO Ethical Committee (EC2010/140).
Sample Collection
At 28, 43, and 58 wk of breeder flock age, 20 eggs per maternal treatment (5 eggs per pen) were collected randomly. Yolks were separated and pooled per 5 (4 replicates of 5 yolks per maternal treatment). At hatch, after incubation of eggs from 28-, 43-, and 58-wk-old breeders, 25 chicks per maternal treatment were randomly selected and euthanized by cervical dislocation. Residual yolk was removed and pooled by 5 to obtain 5 replicates per maternal treatment. Yolk and residual yolk samples were freeze-dried for 48 h, ground, and kept frozen at −20
• C until analysis. In every offspring trial (from 28-, 43-, and 58-wk-old breeders), livers were removed from 48 one-day-old chicks per maternal treatment (8 chicks per pen), and pooled by 8 per pen (6 replicates per maternal treatment). At d 14, 28, and 38 posthatch, liver samples were collected from 6 chicks (1 chicks per pen) of each dietary treatment. These 1 LNA = linolenic acid (C18:2n-6), ALA = α-linoleic acid (C18:3n-3), ARA = arachidonic acid (C20:4n-6), EPA = eicosapentaenoic acid (C20:5n-3), DHA = docosahexaenoic acid (C22:6n-3) concentration given in mg/100 g of feed. CON, EPA = DHA, DHA, and EPA are the 4 maternal dietary treatments: CON: control diet; EPA = DHA: n-3 enriched diet where the EPA concentration equals the DHA concentration; DHA: n-3 enriched diet in which the DHA concentration doubles the EPA concentration; EPA: n-3 enriched diet in which the EPA concentration doubles the DHA concentration. n = 9 for the breeder diet (4 rearing and 5 laying batch), n = 1 for offspring starter, grower, and finisher batch. ND = not detected. The superscripts a, b and c refer to significant differences (P < 0.05).
samples were individually ground and kept frozen at −20
• until analysis.
FA Analysis
Total lipids were extracted from 5 g of freezedried and pooled (residual) yolk samples using chloroform/methanol (2:1 vol/vol) and methylated using methanolic HCl, as described by Koppenol et al. (2014a) . For total lipid extraction of liver samples, 5.5 mL of deionized water, 20 mL of chloroform, and 40 mL of methanol was added to each 15-g liver sample. After mixing for 2 min, an additional 10 mL of deionized water was added and mixed for 1 min. Then 20 mL of chloroform was added and mixed for 30 s (adapted from Sukhija and Palmquist, 1988) . Liver samples were then transferred to a separating funnel.
After 12 h, the extract was collected, dried, methylated, and analyzed by gas chromatography as described by Koppenol et al. (2014a) . The FA concentrations were calculated in milligrams per 100 g of tissue, using following formula:
with m FA = the weight of the FA of interest, A FA = the peak area of the FA of interest, m IS = the weight of the internal standard (C19:0), A IS = the peak area of the internal standard, fat % =
m t o t a l e x t r a c t m t i s s u e s a m p l e , DM % = m l y o p h y l i z e d t i s s u e m f r e s h t i s s u e
(only for yolk and residual yolk), m extract = the weight of that part of the extract used for further methylation. Peak areas of all measured FA between C12:0 and C22:0 were determined.
Data and Statistical Analysis
At 3 different breeder flock ages (28-43-58 wk), 80 yolks were collected and pooled by 5 to result in 4 replicates per treatment (experimental unit = 5 pooled yolks) and 100 residual yolks from nearly hatched chicks were sampled and pooled by 5 to result in 5 replicates per treatment (experimental unit = 5 pooled residual yolks). During each offspring trial, 192 livers from 1-d-old chicks, 24 livers from 14-d-old chicks, 24 livers from 28-d-old chicks, and 24 livers from 38-d-old chicks were sampled. The livers from 1-d-old chicks were pooled by 8 to result in 6 replicates per treatment (experimental unit = 8 pooled 1-d-old chick livers), whereas 6 livers per treatment of 14-, 28-, and 38-d-old chicks were analyzed individually (experimental unit = 1 liver). All data were analyzed using STA-TISTICA 11 (StatSoft Inc., Tulsa, OK). Concentrations of FA were analyzed using a full factorial ANOVA with treatment and breeder flock age as categorical variables. Significant differences between treatments, ages and their interactions were tested with a post hoc Tukey test. Differences due to treatment, age, and their interaction effects were considered significant if the P-value was <0.05. Data are shown as means ± SEM.
RESULTS
Breeder Flock Age Effect
The n-6/n-3 ratio in the yolk, RY, and liver at d 1 was not affected by breeder age. At d 14, however, offspring from young breeders (28 wk) had a lower hepatic n-6/n-3 ratio compared with offspring from older breeders (43 and 58 wk; P = 0.0001). This was only due to a significant lower n-6/n-3 ratio in the control group (P = 0.0090) at start of lay compared with later breeder flock ages, because in the other treatments n-6/n-3 did not differ with breeder age (data not shown). Another 14 d later (d 28), hepatic n-6/n-3 ratio was higher for mid-lay (43 wk) offspring compared with end-lay (58 wk) offspring, with the hepatic n-6/n-3 ratio of offspring from 28-wk-old breeders being intermediate (P = 0.0164; Figure 1A) .
The LNA and ALA were incorporated into the yolk of younger hens (28 wk) at higher concentrations compared with older hens (43 and 58 wk; P < 0.0001 and P < 0.0001 for LNA and ALA, respectively), whereas LNA concentrations in the RY were highest in older flocks (58 wk) compared with their younger counterparts (28 and 43 wk; P = 0.0185) and ALA concentrations did not differ with breeder age. At 14 d of age, hepatic LNA (P < 0.0001) and ALA (P < 0.0001) concentrations were lowest in offspring from 43-wk-old breeders, next lowest in offspring from 58-wk-old breeders, and highest in offspring from 28-wk-old breeders. At this age an interaction arose between breeder age and treatment for hepatic LNA (P = 0.0119) and ALA (P = 0.0281) concentrations. Hepatic LNA concentrations were highest in every treatment when offspring were from young breeders (28 wk) compared with older breeders (43 and 58 wk), except for the DHA treatment. When breeders were fed DHA, liver from offspring from old (58 wk) breeders contained as much LNA as liver from offspring from young breeders (28 wk). Offspring from control-fed breeders had a equally lower hepatic ALA concentrations when from 43-and 58-wk-old breeders, compared with 28-wk-old breeders, whereas offspring from EPA = DHA-, DHA-, and EPA-fed breeders had lower hepatic ALA concentrations when from 43-wk-old breeders, compared with 28-and 58-wk-old breeders (data not shown). At 28 d of age, hepatic LNA (P = 0.0168) and ALA (P = 0.0002) concentrations were lower in offspring from mid-lay breeders, compared with their younger and older counterparts ( Figure 1B,C) .
Concentrations of ARA in the RY increased with breeder flock age (P < 0.0001), but hepatic ARA concentrations were lower at 14 (P < 0.0001) and 38 (P = 0.0442) d posthatch in offspring from older breeders (58 wk) compared with offspring from younger breeders (28 wk; Figure 1D ). At d 28 posthatch, an interaction was found between breeder age and treatment (P = 0.0111). Only offspring from EPA-fed breeders had higher hepatic ARA concentrations when from 58-wk-old breeders compared with offspring from 28-wk-old breeders, with those from 43-wk-old EPA-fed breeders being intermediate.
The EPA was present in the highest amounts in the residual yolk of offspring produced mid-lay (43 wk; P = 0.0317), but hepatic EPA in 14-, 28-, and 38-d-old offspring was always higher in offspring of young breeders (28 wk) compared with older breeders (43 and 58 wk; P < 0.0001, P < 0.0001, and P = 0.0008, respectively; Figure 1E ). At d 14 and 28, an interaction was observed between breeder age and treatment (P = 0.0023 and P = 0.0391, respectively). At 14 d of age, hepatic EPA concentrations were higher for offspring from young breeders (28 wk) fed the control diet, EPA = DHA diet, and DHA diet, compared with offspring from both 43-and 58-wk-old breeders, whereas when breeders were fed the EPA diet, the hepatic EPA concentrations of the offspring coming from 43-wk-old breeders were intermediate (data not shown). At 28 d of age, the hepatic EPA concentrations of the offspring from control, EPA = DHA, and DHA breeders were highest when from young breeders (28 wk), lowest when from 43-wk-old breeders, and intermediate when from old breeders (58 wk), but not affected by breeder age when breeders were fed the EPA diet (data not shown).
Incorporation of DHA in the yolk decreased with breeder age (P = 0.0047), whereas the concentration in the RY increased with breeder age (P = 0.0110). Hepatic DHA concentrations were higher (P < 0.0001) at d 14 when offspring came from young breeders (28 wk) compared with older breeders (43 and 58 wk), whereas at d 28 hepatic DHA concentrations were higher (P = 0.0127) when offspring came from older breeders (58 wk) compared with younger breeders (28 and 43 wk; Figure 1F ). An interaction between breeder age and treatment was found at d 14 (P = 0.0138) and 28 (P = 0.0043). At d 14, hepatic DHA concentrations were higher for offspring from 28-wk-old breeders compared with 43-and 58-wk-old breeders fed the control or the EPA = DHA diet. Hepatic DHA concentrations were higher for offspring from 28-wk-old breeders compared with 43-wk-old breeders, with 58-wk-old breeders intermediate when fed the DHA diet. When fed the EPA diet, hepatic DHA concentrations were higher for offspring from 28-wk-old breeders compared with 58-wk-old breeders, with 43-wk-old breeders intermediate. At 28 d of age, hepatic DHA concentrations were only higher in offspring from 58-wk-old breeders compared with younger breeders fed the EPA diet (data not shown).
At 14 d posthatch, this difference in hepatic EPA concentration was due to differences between offspring from control-fed and DHA-fed breeders only, as an interaction was found between breeder age and treatment (P = 0.0087). The DHA concentrations in residual yolk increased with breeder flock age (P < 0.0001; Figure 1E ). However, an interaction effect was found for DHA concentrations in the residual yolk between breeder age and treatment. For DHA-and EPA-fed breeders only, residual yolk DHA concentrations increased with age (P = 0.0058). Hepatic DHA concentrations, however, were lower for 14-d-old (P < 0.0001) and higher for 28-d-old offspring (P = 0.0043) from older hens (43 and 58 wk) compared with hepatic concentrations in offspring from younger hens (28 wk; Figure 1F ).
n-3 Treatment Effect
The n-6/n-3 ratio was lower in the yolk (P < 0.0001), RY (P < 0.0001), liver at d 1 (P < 0.0001) and at d 14 (P < 0.0001) when breeders were fed an n-3 supplemented diet (EPA = DHA, DHA, and EPA) compared with control-fed breeders (Figure 2A ). An interaction was calculated at d 14 between treatment and breeder age (P = 0.0090). Hepatic n-6/n-3 ratio did not differ in offspring from 28-wk-old breeders, but only in offspring from 43-and 58-wk-old breeders (data not shown). At 28 d, however, hepatic n-6/n-3 ratio was intermediate for offspring from EPA-and DHA-fed breeders (P = 0.0073), whereas at d 38, offspring from DHA-fed breeders had the highest hepatic n-6/n-3 ratio and offspring from EPA = DHA-fed breeders the lowest, with offspring from control-and EPA-fed breeders being intermediate (P = 0.0076; Figure 2A) .
Supplementation of n-3 FA to the breeder diet resulted in lower concentrations of LNA in the yolk (P < 0.0001) compared with the control diet, whereas feeding an EPA diet resulted in intermediate LNA concentrations in the RY (P = 0.0067), but did not affect the hepatic LNA concentrations of the offspring until d 38 posthatch ( Figure 2B ). At 38 d posthatch, hepatic LNA concentrations were lower for offspring coming from EPA = DHA-fed breeders compared with DHA-fed breeders, with control-and EPA-fed breeders being intermediate (P = 0.0175). Supplementation of DHA to the diet of breeder hens resulted in a lower incorporation of ALA in the yolk compared with EPA supplementation or the control treatment, with the EPA = DHA treatment being intermediate (P = 0.0002). In the residual yolk, however, ALA concentrations were lower for EPA = DHA-fed breeders compared with control-fed breeders, with the DHA-and EPAfed breeders intermediate (P = 0.0228; Figure 2C ). Only at d 14 posthatch were hepatic ALA concentrations affected by maternal treatment, resulting in lower hepatic ALA concentrations in offspring from EPA = DHA-fed breeders compared with DHA-fed breeders (P = 0.0173; Figure 2C ).
The ARA was incorporated at a lower degree in the yolk and RY of eggs from n-3-supplemented hens (P < 0.0001), together with lower ARA concentrations in the residual yolk (P < 0.0001), but hepatic ARA concentrations of the offspring were not affected at any age ( Figure 2D ).
Yolk EPA concentrations highly resembled dietary EPA supplementation: EPA concentrations were highest in yolk from EPA-supplemented hens, next-tohighest in yolk from EPA = DHA-fed hens, nextto-lowest in yolk from DHA-fed hens, and not detectable in egg yolk from control hens (P < 0.0001; Figure 2E ). However, an interaction between treatment and breeder age effect was found (P = 0.0159). From 43 wk of age onward, EPA concentrations in the yolk of eggs laid by EPA = DHA-fed hens were no longer significantly different from eggs laid by DHA-fed hens and at 58 wk of age even no longer different from eggs laid by EPA-fed hens (data not shown). The EPA concentrations in the residual yolk of eggs laid by EPA = DHA-and EPA-fed breeders were highest; EPA concentrations were next-to-highest in the residual yolk of eggs laid by DHA-fed breeders and lowest in control eggs (P < 0.0001), following the same pattern as the yolk ( Figure 2E ). Offspring hepatic EPA concentrations at d 1 were higher for all n-3 treatments compared with the control treatment (P = 0.0010). At d 14 posthatch, hepatic EPA concentrations were higher in offspring from EPA = DHA-and EPA-fed breeders compared with control-and DHAfed breeders (P < 0.0001; Figure 2E ). This was only due to the difference in offspring from young breeders (28 wk), because hepatic EPA concentrations did not differ between treatments at later breeder ages (43 and 58 wk), as interaction arose (P = 0.0023; data not shown). At 28 d posthatch, hepatic EPA concentrations were higher in offspring from n-3-supplemented breeders, compared with control-fed breeders (P = 0.0002; Figure 2E ), due to significant differences between treatments in offspring from 58-wk-old breeders. Because at the other breeder ages offspring hepatic EPA concentrations were not affected by treatment, an interaction was found (P = 0.0391; data not shown).
Yolk DHA concentrations highly resembled dietary DHA supplementation: DHA concentrations were highest in yolk from DHA-and DHA = EPA-enriched eggs, lowest in control eggs, and intermediate in EPAenriched eggs (P < 0.0001; Figure 2F ). Interaction between treatment and breeder age arose for yolk DHA concentrations (P = 0.0333). At 28 and 43 wk of age, yolk from all n-3-supplemented treatments had equally higher DHA concentrations compared with the control treatment. At 58 wk of age, however, eggs laid by DHA-fed hens contained more DHA in their yolk compared with eggs from EPA-fed breeders, with EPA = DHA-fed breeders intermediate (data not shown). Concentrations of DHA in the RY were higher for all n-3 treatments compared with the control treatment (P < 0.0001). At d 1, hepatic DHA concentrations of offspring from EPA = DHA-and DHA-fed breeders were higher than offspring from control-fed breeders with offspring from EPA-fed breeders intermediate (P = 0.0119). Offspring hepatic DHA concentrations were lower and no longer affected by treatment further onward ( Figure 2F ).
DISCUSSION
Breeder Flock Age Effect
It is known that the mechanisms involved in lipid metabolism and lipoprotein transfer are influenced by breeder age (Nielsen, 1998; Burnham et al., 2001) . Therefore, in this trial breeder age is taken into account as eggs were collected at different ages. However, the experiment is not structured to expose breeders to the different test diets at these different ages; rather, breeders were fed the supplemented diets over the entire experimental period, so there may be effects due to maternal tissue saturation with n-3 FA.
Residual yolk fat content increased with breeder flock age, which was also found by Yadgary et al. (2010) . However, the ratio of n-6/n-3 in the yolk, residual yolk, and liver at hatch was not affected by age, suggesting that accumulation of certain FA does not occur in tissue of the breeder hens. Even if n-3 FA accumulated in the breeder's tissue, the incorporation into the yolk was not affected. However, a beneficial effect of adding n-3 FA to the diet of younger breeders to lower the hepatic n-6/n-3 ratio of the offspring at 14 d was found.
From 14 d onward, the offspring from older hens had a different approach to deal with the incorporation, transportation, and use of EPA. Concentrations of EPA in the liver were higher in offspring from younger hens, compared with offspring from older hens. Although DHA incorporation in the yolk decreased and DHA remaining in the residual yolk increased with breeder flock age, breeder flock age did not affect DHA concentrations in the liver of the offspring at hatch. At 14 and 28 d posthatch, however, hepatic DHA concentrations were respectively highest and lowest in offspring from younger breeders. This age effect on LC PUFA incorporation in the liver of the offspring has to our knowledge not yet been described in the literature. Koppenol et al. (2014b) already described the effect of EPA and DHA supplementation on chick weight at hatch and their consequently altered performance of the offspring during the starter period. This trial indicates that n-3 supplementation also affected EPA and DHA incorporation into the yolk and transfer to the progeny. The progeny starts at hatch with those FA that have been incorporated (or metabolized) during incubation and what remains in the residual yolk. By d 14 the process of continued unidirectional movement from the residual yolk to the liver is completely finished and the liver becomes the principal organ responsible for redistributing FA among lipid classes and tissues. The n-3 FA present in the liver will be used for synthesis/formation of essential tissue components such as nerves, brains, and eyes and become sequestered in red blood cells. When a higher amount of a specific FA is present in the yolk, more of it can be transferred to the blood circulation of the chick. Maternal supplementation of n-3 FA, EPA, and DHA were incorporated in the yolk and transferred via the residual yolk to became available for the developing embryo and resulted in elevated EPA and DHA concentrations in the liver of the offspring at hatch.
n-3 Fatty Acid Treatment Effect
The EPA was transferred from the yolk to the liver of the embryos, resulting in higher hepatic EPA concentrations at hatch. Not only the liver of 1-d-old offspring contained more EPA, being available for the developing offspring, but also the EPA concentrations in the residual yolk were elevated in a way resembling the initial composition of the yolk. This residual yolk continues to be consumed during perinatal life; therefore, it serves as a lasting source for EPA to the developing offspring, for at least another 6 d posthatch (Romanoff, 1960) . Offspring from EPA-supplemented breeders therefore had more access to EPA to either use it as a source for eicosanoid production (Zhou and Nilsson, 2001 ) such as thromboxanes, leukotrienes, or prostaglandins, or to incorporate it into membranes of tissues such as brain or eyes (Speake et al., 1998) . The proportion of EPA to the total FA concentration reached its maximum at d 14 posthatch and slowly decreased thereafter, especially when EPA was present at higher levels. Offspring from control eggs started with none or little hepatic EPA and remained lower in comparison with the other treatments during posthatch growth. This indicates de novo synthesis from its precursor ALA, which was originally present at higher concentrations in yolk of controlfed breeders. However, control eggs could not reach the EPA concentration by de novo synthesis compared with the dietary EPA and EPA = DHA groups, due to the low conversion efficiency.
Offspring from DHA = EPA-and DHA-fed breeders had elevated hepatic DHA concentrations at hatch in comparison with offspring from control-fed breeders, in agreement with Pappas et al. (2006) . Maternal EPA supplementation resulted in intermediate elevated hepatic DHA concentrations. Thus, offspring from DHA-fed breeders showed a direct uptake from their maternal feed, whereas offspring from EPA-fed breeders obtained an equal amount of hepatic DHA at hatch due to conversion of EPA into DHA. DHA] plays a crucial role in brain and neural development and is crucial to be available to the developing chick in this perinatal period (Simopoulos et al., 1986; Innis, 1991) . From human research, it is known that during pregnancy, the requirement for DHA is maximal during the last trimester and stabilizes at 2 yr postpartum corresponding to a rapid rate of cell proliferation and membrane synthesis (Clandinin et al., 1980; Ghebremeskel et al., 2000) . Moreover, during the last intrauterine trimester and the first 18 mo of human postnatal life, DHA accumulates rapidly in the brain (Martinez, 1991) . Ajuyah et al. (2003) showed that lowering the n-6/n-3 ratio in the maternal chicken diet resulted in higher DHA concentrations in the brain of offspring up to 6 wk posthatch. We can speculate on a certain advantage for offspring of n-3-supplemented breeders, because they had more hepatic DHA available at d 1 posthatch, which they obviously used during their first 14 d posthatch. The proportion of hepatic DHA to total FA decreased steadily further in posthatch life, highlighting the importance of this FA during early development in agreement with Ajuyah et al. (2003) .
When higher levels of n-3 FA were added to the maternal diet, lower concentrations of LNA and ARA were incorporated into the yolk and residual yolk of the offspring. This altered the n-6/n-3 ratio in the developing embryo, favoring the accumulation of EPA and DHA in tissue, because conversion from LNA to EPA and DHA is more effective when competing amounts of n-6 are lower (Goyens et al., 2006) . Moreover, incorporation of EPA and DHA is more effective when directly supplemented compared with being converted from its precursor (Brenna, 2002; Burdge and Wootton, 2002) .
Dietary FA directly obtained from the posthatch feed became deposited in the liver of the offspring at higher concentrations compared with FA obtained from maternal transition. Hepatic deposition of for example dietary ARA was high because the concentration in the posthatch diet was high, outweighing the effect of the maternal transition. In contrast, the maternal transition of EPA and DHA to the liver is rather important because these FA are absent in the posthatch diet.
In conclusion, maternal supplementation of n-3 FA, EPA, and DHA was incorporated in the yolk and transferred via the residual yolk to became available for the developing embryo and resulted in elevated EPA and DHA concentrations in the liver of the offspring at hatch. Maternal n-3 FA supplementation affected the offspring hepatic EPA concentrations up to 28 d of age, whereas the hepatic DHA concentrations were only affected in the early perinatal period. Whether or not the health and immune response of the offspring of n-3 supplemented breeders will be altered will be investigated in future work. As stated earlier by Decrock et al. (2001) , it is also worth noting that the preferential transition of essential PUFA performed by the YSM during avian development is somewhat analogous to the preferential delivery of n-3 and n-6 PUFA to the fetus that is mediated by the placenta during mammalian development (Ruyle et al., 1990) . In this respect, the chicken can possibly be used as a model for human FA transfer to the developing embryo.
